131 related articles for article (PubMed ID: 14980483)
41. G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV.
Madireddy A; Purushothaman P; Loosbroock CP; Robertson ES; Schildkraut CL; Verma SC
Nucleic Acids Res; 2016 May; 44(8):3675-94. PubMed ID: 26837574
[TBL] [Abstract][Full Text] [Related]
42. Rapid and quantitative assessment of KSHV LANA-mediated DNA replication.
De León Vázquez E; Kaye KM
Arch Virol; 2011 Aug; 156(8):1323-33. PubMed ID: 21472413
[TBL] [Abstract][Full Text] [Related]
43. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
[TBL] [Abstract][Full Text] [Related]
44. The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation.
Kwun HJ; da Silva SR; Qin H; Ferris RL; Tan R; Chang Y; Moore PS
Virology; 2011 Apr; 412(2):357-65. PubMed ID: 21324504
[TBL] [Abstract][Full Text] [Related]
45. Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA.
Domsic JF; Chen HS; Lu F; Marmorstein R; Lieberman PM
PLoS Pathog; 2013; 9(10):e1003672. PubMed ID: 24146617
[TBL] [Abstract][Full Text] [Related]
46. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
[TBL] [Abstract][Full Text] [Related]
47. Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes.
Collins CM; Medveczky PG
Adv Cancer Res; 2002; 84():155-74. PubMed ID: 11883526
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.
Chiu YF; Sugden AU; Fox K; Hayes M; Sugden B
J Cell Biol; 2017 Sep; 216(9):2745-2758. PubMed ID: 28696226
[TBL] [Abstract][Full Text] [Related]
49. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus.
Zaldumbide A; Ossevoort M; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Feb; 44(6):1352-60. PubMed ID: 16828498
[TBL] [Abstract][Full Text] [Related]
50. Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids.
Shrestha P; Sugden B
J Virol; 2014 Aug; 88(15):8490-503. PubMed ID: 24829342
[TBL] [Abstract][Full Text] [Related]
51. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
52. Control of Viral Latency by Episome Maintenance Proteins.
De Leo A; Calderon A; Lieberman PM
Trends Microbiol; 2020 Feb; 28(2):150-162. PubMed ID: 31624007
[TBL] [Abstract][Full Text] [Related]
53. Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding.
Kwun HJ; Toptan T; Ramos da Silva S; Atkins JF; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4342-9. PubMed ID: 25271323
[TBL] [Abstract][Full Text] [Related]
54. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
55. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
56. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.
Park J; Lee MS; Yoo SM; Jeong KW; Lee D; Choe J; Seo T
J Virol; 2007 Nov; 81(22):12680-4. PubMed ID: 17855527
[TBL] [Abstract][Full Text] [Related]
57. Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.
Si H; Verma SC; Robertson ES
J Virol; 2006 Sep; 80(18):9017-30. PubMed ID: 16940514
[TBL] [Abstract][Full Text] [Related]
58. Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence.
Griffiths R; Harrison SM; Macnab S; Whitehouse A
J Gen Virol; 2008 Nov; 89(Pt 11):2843-2850. PubMed ID: 18931082
[TBL] [Abstract][Full Text] [Related]
59. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus.
Calderwood MA; Hall KT; Matthews DA; Whitehouse A
J Gen Virol; 2004 Jan; 85(Pt 1):147-153. PubMed ID: 14718629
[TBL] [Abstract][Full Text] [Related]
60. Topological implications of DNA tumor viral episomes.
Kim ET; Kim KD
BMB Rep; 2022 Dec; 55(12):587-594. PubMed ID: 36379513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
